Lymphatic system and adipose tissue: Crosstalk in health and disease

The lymphatic system (LS) is one of the main integrative systems of the body, providing protective and transport functions. In recent years, interactions between LS and adipose tissue (AT) have been of particular interest. Lymphatic vessels play an important role in metabolic and regulatory function...

Full description

Bibliographic Details
Main Authors: V. V. Klimontov, D. M. Bulumbaeva
Format: Article
Language:English
Published: Endocrinology Research Centre 2021-10-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://www.omet-endojournals.ru/jour/article/view/12776
_version_ 1797204562644303872
author V. V. Klimontov
D. M. Bulumbaeva
author_facet V. V. Klimontov
D. M. Bulumbaeva
author_sort V. V. Klimontov
collection DOAJ
description The lymphatic system (LS) is one of the main integrative systems of the body, providing protective and transport functions. In recent years, interactions between LS and adipose tissue (AT) have been of particular interest. Lymphatic vessels play an important role in metabolic and regulatory functions of AT, acting as a collector of lipolysis products and adipokines. In its turn, hormones and adipocytokines that produced in adipocytes (including leptin, adiponectin, IL-6, TNF-α, etc.) affect the function of lymphatic endothelial cells and control the growth of lymphatic vessels. Cooperation between LS and AT becomes pathogenetically and clinically important in lymphedema and obesity. It is known that both primary and secondary lymphedema are characterized by increased fat accumulation which is associated with the severity of lymphostasis and inflammation. Similarly, in obesity, the drainage function of LS is impaired, which is accompanied by perilymphatic mononuclear infiltration in the AT. The development of these changes is facilitated by endocrine dysfunction of adipocytes and impaired production of adipocytokines. The increase in the production of inflammatory mediators and the disruption of the traffic of inflammatory cells causes a further deterioration in the outflow of interstitial fluid and exacerbates the inflammation of the AT, thereby forming a vicious circle. The role of lymphangiogenesis in AT remodeling in obesity needs further research. Another promising area of research is the study of the role of intestinal LS in the development of obesity and related disorders. It has been shown that the transport of chylomicrons from the intestine depends on the expression of a number of molecular mediators (VEGF-C, DLL-4, neuropilin-1, VEGFR-1, CD36/FAT, etc.)in the endotheliocytes of the intestinal lymphatic vessels, as well as the functioning of «push-button» and “zippering” junctions between endothelial cells. New approach to the treatment of obesity based on blockade of lymphatic chylomicrontransport has been experimentally substantiated. Further identification of the molecular mechanisms and signaling pathways that determine the remodeling of AT in lymphedema and obesity are likely to provide new approaches to the treatment of these diseases.
first_indexed 2024-03-08T09:12:36Z
format Article
id doaj.art-d2425ea0efb949e8b381abd7058daa71
institution Directory Open Access Journal
issn 2071-8713
2306-5524
language English
last_indexed 2024-04-24T08:37:12Z
publishDate 2021-10-01
publisher Endocrinology Research Centre
record_format Article
series Ожирение и метаболизм
spelling doaj.art-d2425ea0efb949e8b381abd7058daa712024-04-16T16:16:13ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242021-10-0118333634410.14341/omet1277610889Lymphatic system and adipose tissue: Crosstalk in health and diseaseV. V. Klimontov0D. M. Bulumbaeva1Research Institute of Clinical and Experimental Lymphology — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of SciencesResearch Institute of Clinical and Experimental Lymphology — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of SciencesThe lymphatic system (LS) is one of the main integrative systems of the body, providing protective and transport functions. In recent years, interactions between LS and adipose tissue (AT) have been of particular interest. Lymphatic vessels play an important role in metabolic and regulatory functions of AT, acting as a collector of lipolysis products and adipokines. In its turn, hormones and adipocytokines that produced in adipocytes (including leptin, adiponectin, IL-6, TNF-α, etc.) affect the function of lymphatic endothelial cells and control the growth of lymphatic vessels. Cooperation between LS and AT becomes pathogenetically and clinically important in lymphedema and obesity. It is known that both primary and secondary lymphedema are characterized by increased fat accumulation which is associated with the severity of lymphostasis and inflammation. Similarly, in obesity, the drainage function of LS is impaired, which is accompanied by perilymphatic mononuclear infiltration in the AT. The development of these changes is facilitated by endocrine dysfunction of adipocytes and impaired production of adipocytokines. The increase in the production of inflammatory mediators and the disruption of the traffic of inflammatory cells causes a further deterioration in the outflow of interstitial fluid and exacerbates the inflammation of the AT, thereby forming a vicious circle. The role of lymphangiogenesis in AT remodeling in obesity needs further research. Another promising area of research is the study of the role of intestinal LS in the development of obesity and related disorders. It has been shown that the transport of chylomicrons from the intestine depends on the expression of a number of molecular mediators (VEGF-C, DLL-4, neuropilin-1, VEGFR-1, CD36/FAT, etc.)in the endotheliocytes of the intestinal lymphatic vessels, as well as the functioning of «push-button» and “zippering” junctions between endothelial cells. New approach to the treatment of obesity based on blockade of lymphatic chylomicrontransport has been experimentally substantiated. Further identification of the molecular mechanisms and signaling pathways that determine the remodeling of AT in lymphedema and obesity are likely to provide new approaches to the treatment of these diseases.https://www.omet-endojournals.ru/jour/article/view/12776lymphatic systemadipose tissuelymphangiogenesislymphedemaobesity
spellingShingle V. V. Klimontov
D. M. Bulumbaeva
Lymphatic system and adipose tissue: Crosstalk in health and disease
Ожирение и метаболизм
lymphatic system
adipose tissue
lymphangiogenesis
lymphedema
obesity
title Lymphatic system and adipose tissue: Crosstalk in health and disease
title_full Lymphatic system and adipose tissue: Crosstalk in health and disease
title_fullStr Lymphatic system and adipose tissue: Crosstalk in health and disease
title_full_unstemmed Lymphatic system and adipose tissue: Crosstalk in health and disease
title_short Lymphatic system and adipose tissue: Crosstalk in health and disease
title_sort lymphatic system and adipose tissue crosstalk in health and disease
topic lymphatic system
adipose tissue
lymphangiogenesis
lymphedema
obesity
url https://www.omet-endojournals.ru/jour/article/view/12776
work_keys_str_mv AT vvklimontov lymphaticsystemandadiposetissuecrosstalkinhealthanddisease
AT dmbulumbaeva lymphaticsystemandadiposetissuecrosstalkinhealthanddisease